Making progress in autism drug discovery

7Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

Abstract

Currently, there are still just two medications approved by the U.S. FDA to treat the irritability that is often found in children with autism spectrum disorder (ASD). Furthermore, there are no drugs approved that treat the core symptoms of ASD. And while many drugs have had good outcomes in preclinical animal models, they have been met with very little success in human clinical trials. There are several factors likely contributing to this problem starting with the heterogeneity within the ASD phenotype. It is therefore important that researchers develop their knowledge about the neurobiological basis of ASD as well as possible subgroups within the disorder, based on either specific behavioral profiles or biological pathways. Furthermore, the development of valid biological markers will allow researchers to use more than parent or teacher reports to determine if a treatment is effective. This author believes that there a good chance of finding effective pharmacological treatments for the core symptoms of ASD with this increased knowledge of the biology and etiology.

References Powered by Scopus

Sniffing neuropeptides: A transnasal approach to the human brain

1146Citations
N/AReaders
Get full text

Effects of STX209 (Arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: A randomized, controlled, phase 2 trial

272Citations
N/AReaders
Get full text

Oxytocin enhances brain function in children with autism

255Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Microbiota and Neurological Disorders: A Gut Feeling

101Citations
N/AReaders
Get full text

Reversal of social deficits by subchronic oxytocin in two autism mouse models

52Citations
N/AReaders
Get full text

Oxytocin normalizes altered circuit connectivity for social rescue of the Cntnap2 knockout mouse

37Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Chadman, K. K. (2014). Making progress in autism drug discovery. Expert Opinion on Drug Discovery, 9(12), 1389–1391. https://doi.org/10.1517/17460441.2014.962511

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 16

73%

Researcher 6

27%

Readers' Discipline

Tooltip

Medicine and Dentistry 9

47%

Agricultural and Biological Sciences 4

21%

Psychology 4

21%

Neuroscience 2

11%

Save time finding and organizing research with Mendeley

Sign up for free